Development of Discordant Hypermetabolic Prostate Cancer Lesions in the Course of [(177)Lu]PSMA Radioligand Therapy and Their Possible Influence on Patient Outcome

SIMPLE SUMMARY: Discordant FDG-positive but PSMA-negative (FDG+/PSMA−) metastases constitute a negative prognostic marker of overall survival in patients undergoing PSMA radioligand therapy (RLT). The aim of this analysis was to investigate the prognostic implications of new FDG+/PSMA− lesions, whic...

Descripción completa

Detalles Bibliográficos
Autores principales: Hartrampf, Philipp E., Lapa, Constantin, Serfling, Sebastian E., Buck, Andreas K., Seitz, Anna Katharina, Meyer, Philipp T., Ruf, Juri, Michalski, Kerstin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428347/
https://www.ncbi.nlm.nih.gov/pubmed/34503080
http://dx.doi.org/10.3390/cancers13174270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428347/
https://www.ncbi.nlm.nih.gov/pubmed/34503080
http://dx.doi.org/10.3390/cancers13174270

Ejemplares similares